Abstract
Diffusion-weighted imaging (DWI) is routinely used to aid in the detection and characterization of prostate cancer. Given imaging time constraints in a clinical setting, it is important to maximize the statistical efficiency of a DWI examination of the prostate. The objective is to maximize the accuracy with which microstructural information about the prostate can be obtained while minimizing diffusion scan time.
In this study, we apply estimation theory to evaluate the statistical efficiency of different DWI acquisitions and methods. Specifically, we show that the variance of DWI parameters estimated using nonlinear multiexponential signal models is considerably higher than the variance observed using linear signal models. We then derive a simple analytical expression for the efficiency of a linear estimator and use it to optimize b-value sampling for DWI of the prostate.
Competing Interest Statement
Anders M Dale is a founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. and receives funding through research agreements with General Electric Healthcare. The terms of these arrangements have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. Tyler M Seibert reports honoraria from Multimodal Imaging Services Corporation, Varian Medical Systems, and WebMD; he has an equity interest in CorTechs Labs, Inc. and also serves on its Scientific Advisory Board. These companies might potentially benefit from the research results. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies.
Funding Statement
This work was supported by funding from the following sources: NIH/NIBIB (K08EB026503) and the Prostate Cancer Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
